北京德恒律师事务所 关于北汽蓝谷新能源科技股份有限公司 2025 年第三次临时股东会的 法律意见 法律意见 德恒 01G20250023-04 号 北京德恒律师事务所 关于北汽蓝谷新能源科技股份有限公司 2025 年第三次临时股东会的 北京市西城区金融街 19 号富凯大厦 B 座 12 层 电话:010-52682888 传真:010-52682999 邮编:100033 北京德恒律师事务所 关于北汽蓝谷新能源科技股份有限公司 2025 年第三次临时股东会的法律意见 致：北汽蓝谷新能源科技股份有限公司 北汽蓝谷新能源科技股份有限公司（以下简称"公司"）2025 年第三次临 时股东会（以下简称"本次会议"）于 2025 年 11 月 26 日（星期三）召开。北 京德恒律师事务所（以下简称"德恒"）受公司委托，指派廖齐越律师、王瑞芸 律师（以下简称"德恒律师"），根据《中华人民共和国证券法》（以下简称"《证 券法》"）、《中华人民共和国公司法》（以下简称"《公司法》"）、中国证 券监督管理委员会《上市公司股东会规则》（以下简称"《股东会规则》"）、 《北汽蓝谷新能源科技股份有限公司章程》（以下简称"《公司章程》" ...

北汽蓝谷新能源科技股份有限公司 章程 （已经公司 2025 年第三次临时股东会审议通过） 1 目录 | 第一章 | 总则 | 4 | | --- | --- | --- | | 第二章 | 经营宗旨和范围 | 6 | | 第三章 | 股份 | 7 | | 第一节 | 股份发行 | 7 | | 第二节 | 股份增减和回购 | 8 | | 第三节 | 股份转让 | 9 | | 第四章 | 股东和股东会 | 11 | | 第一节 | 股东的一般规定 | 11 | | 第二节 | 控股股东和实际控制人 | 15 | | 第三节 | 股东会的一般规定 | 16 | | 第四节 | 股东会的召集 | 19 | | 第五节 | 股东会的提案与通知 | 21 | | 第六节 | 股东会的召开 | 23 | | 第七节 | 股东会的表决和决议 | 27 | | 第五章 | 公司党委 | 33 | | 第六章 | 董事和董事会 | 35 | | 第一节 | 董事的一般规定 | 35 | | 第二节 | 董事会 | 39 | | 第三节 | 独立董事 | 46 | | 第四节 | 董事会专门委员会 | 49 | | 第七章 | 高 ...

Core Viewpoint - The company, Beiqi Blue Valley, has received approval from the China Securities Regulatory Commission for a private placement of shares to raise up to 6 billion yuan for new energy vehicle development and AI intelligent platform projects [2][3]. Financing Details - The company plans to raise a total of 6 billion yuan through a non-public offering of shares [3]. - The registration for this financing was effective as of November 20, 2025 [2][3]. Project Investments - The total investment for the new energy vehicle development project is approximately 742.545 million yuan, which includes the development of various models such as sedans, SUVs, and MPVs under the Arcfox and Xiangjie brands [4]. - The AI intelligent platform and advanced driving electric system development project has a total investment of 1.372 billion yuan, focusing on creating a scenario-based intelligent cockpit and a comprehensive driving platform [4]. Strategic Goals - The implementation of these projects aims to enhance the company's product variety in the new energy vehicle sector, thereby improving brand recognition, sales, and market share [4]. - The AI platform development will leverage existing technological foundations and open-source computing platforms to meet diverse electric vehicle needs across various scenarios [5].

Core Points - The company has received approval from the China Securities Regulatory Commission (CSRC) for the registration of a stock issuance to specific investors [1][2] - The approval is valid for 12 months from the date of registration [2] - The company is required to report any significant events to the Shanghai Stock Exchange before the completion of the stock issuance [2] Company Actions - The company will proceed with the stock issuance according to the approved documents and relevant laws and regulations [1][2] - The company is committed to fulfilling its information disclosure obligations in a timely manner [2]

Core Points - The stock of Beiqi Blue Valley (600733) closed at 7.71 yuan on November 25, 2025, down 1.41% from the previous trading day, with a total market capitalization of 42.972 billion yuan [1] - The company received approval from the China Securities Regulatory Commission (CSRC) on November 24, 2025, for a specific stock issuance, which is valid for 12 months from the date of approval [1] - The company is required to strictly follow the filing documents submitted to the Shanghai Stock Exchange and report any significant events in a timely manner [1] Company Summary - Beiqi Blue Valley's stock opened at 7.79 yuan, reached a high of 7.83 yuan, and a low of 7.70 yuan on the same day, with a trading volume of 650 million yuan and a turnover rate of 1.72% [1] - The company will handle related matters and fulfill information disclosure obligations within the specified timeframe as per the approval and authorization from the shareholders' meeting [1]

Core Points - The company, Beiqi Blue Valley, received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [2] - The approval is valid for 12 months from the date of issuance [2] - The company must adhere to the filing documents and issuance plan submitted to the Shanghai Stock Exchange [2] - Any significant events occurring between the approval and the completion of the issuance must be reported to the Shanghai Stock Exchange [2]

Group 1: Gold Jewelry Price Increase - Multiple domestic gold jewelry brands have raised their gold jewelry prices, with Chow Sang Sang and Lao Feng Xiang both quoting 1315 CNY per gram, while Chow Tai Fook quoted 1312 CNY per gram [1] Group 2: Fund Risk Level Adjustment - China Construction Bank has announced an increase in the risk levels of 87 public fund products, with 32 products moving from "medium-low risk" to "medium risk" and 55 products from "medium risk" to "medium-high risk" [1] Group 3: Charging Battery Regulations - The new national standard for mobile power supplies is expected to increase industry costs by 20%-30%, primarily due to higher quality battery procurement and hardware upgrades [2] - The overall GPU shipments for data centers surged by 145% quarter-on-quarter in Q3, while PC GPU shipments saw a modest increase of 2.5% quarter-on-quarter and 4% year-on-year [2] Group 4: Nvidia Short Selling - Notable short-seller Michael Burry has reiterated his bearish stance on Nvidia, labeling the current AI hype as a "magnificent absurdity" and suggesting that Nvidia is a key indicator of a potential bubble in the AI sector [4] Group 5: Novartis China Team Restructuring - Novartis has announced a change in its operational model for county-level business in China, stating that it will continue to support county-level healthcare despite the restructuring [5] Group 6: Vanke Bond Performance - Vanke's 2027 dollar bond has experienced a record drop, with a decrease of 12 cents to 43.5 cents per dollar, marking the largest single-day decline since its issuance in 2017 [6] Group 7: Regulatory Actions - Hengbang Co. received an administrative regulatory decision from the Shandong Securities Regulatory Bureau due to non-compliance with independent director replacement rules [7] - Coris received a regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable, related party transactions, and insider information management [11] Group 8: Stock Market Performance - The ChiNext Index saw a nearly 2% rebound, with significant trading volume and numerous stocks hitting the daily limit up, particularly in AI application and computing hardware sectors [17]

分组1 - Weili Medical plans to distribute a cash dividend of 2 yuan per 10 shares to all shareholders, based on an undistributed profit of 704 million yuan as of September 30, 2025 [1] - Tongding Interconnect's shareholder plans to reduce their stake by up to 0.49%, equating to a maximum of 605,800 shares [1] - Caitong Securities has received approval from the China Securities Regulatory Commission to issue short-term corporate bonds with a total face value of up to 5 billion yuan [1] 分组2 - Youfu Food intends to use 70 million yuan of its own funds to invest in wealth management products with expected annual returns of up to 4.2% [3] - Keres received an administrative regulatory decision from the Guangdong Securities Regulatory Bureau for violations related to accounts receivable aging calculations and related party transactions [5] - Ouma Software's controlling shareholder has completed the transfer of state-owned equity, changing the controlling shareholder to Shandong Guotou [7] 分组3 - ST Huapeng's wholly-owned subsidiary has completed a major overhaul project and is now in production [8] - Beiqi Blue Valley has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [8] - Weijie Chuangxin received a government subsidy of 5 million yuan, accounting for 21.07% of its projected net profit for 2024 [9] 分组4 - China Resources Double Crane's subsidiary has received a drug registration certificate for a hypertension treatment drug [11] - Huafeng shares are continuing to suspend trading due to a planned change in control [13] - Kaifa Electric's shareholder plans to transfer 36.6869 million shares, representing 11.63% of the total share capital [14] 分组5 - Heng Rui Medicine has received approval for two clinical trials for innovative anti-tumor drugs [15] - Kosen Technology plans to invest 30 million USD to establish a new production base in Malaysia [17] - Sanxing Medical's subsidiary is expected to win a procurement project from the State Grid worth approximately 107 million yuan [18] 分组6 - Sitai Li's subsidiary has received a drug registration certificate for a contrast agent used in MRI [21] - Daren Tang's subsidiary has received a drug registration certificate for a pain relief gel [22] - Saike Xide has received approval for three medical device products, expanding its product range in the in vitro diagnostic field [23] 分组7 - Hasa Lian has elected a new chairman and vice chairman for its board of directors [24] - Two-sided Needle's subsidiary plans to invest 68.8522 million yuan in a production base expansion project [25] - Sunshine Nuohe plans to transfer 70% of its controlling subsidiary's equity for 2 million yuan [26] 分组8 - Hengbang shares received an administrative regulatory decision from the Shandong Securities Regulatory Bureau for failing to complete the election of independent directors [27] - Huali shares plan to sign a related transaction contract worth approximately 59.2847 million yuan [28] - Shangwei shares plan to invest 520.4 million yuan to gain a controlling stake in Sichuan Zhongfu Taihua [30] 分组9 - Zejing Pharmaceutical's ZG006 has been included in the list of breakthrough therapeutic varieties for treating advanced neuroendocrine cancer [32] - Yaopi Glass's shareholder plans to reduce their stake by up to 2.26%, equating to a maximum of 21.1469 million shares [34] - Huate Gas has initiated a major lawsuit involving a claim of 180 million yuan [36] 分组10 - Zhongchumei's controlling shareholder plans to increase their stake by between 42 million and 80 million yuan [37] - Huitong shares' shareholder plans to reduce their stake by up to 1% [38] - Miaowei Exhibition plans to apply for an initial public offering of H shares on the Hong Kong Stock Exchange [40] 分组11 - Tianqi Lithium's subsidiary has appealed to the Chilean Supreme Court regarding a partnership agreement with SQM and Codelco [42] - Naxin Micro plans to repurchase shares worth between 200 million and 400 million yuan [44] - Pingao shares have reported significant uncertainty regarding future business development and profitability [46] 分组12 - Shunyu shares have been pre-selected for a project worth 1.023 billion yuan [48] - Zhongyuan Neipei plans to acquire a 2.5% share in an aerospace industry fund for 50 million yuan [50] - Huifa Food's shareholder plans to reduce their stake by up to 3%, equating to a maximum of 727.14 million shares [53] 分组13 - Junshi Biosciences' subcutaneous PD-1 new formulation has reached its primary endpoint in a Phase III clinical trial [54] - Industrial Fulian clarified that it has not lowered its fourth-quarter profit target amid market rumors [55] - Longpan Technology's subsidiary has signed a major supply agreement for lithium iron phosphate materials, significantly increasing the supply volume [56]

Core Viewpoint - The company has received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [1] Group 1 - The company, Beiqi Blue Valley (600733.SH), announced on November 24, 2025, that it received a notice from the China Securities Regulatory Commission [1] - The approval pertains to the company's application for the registration of stock issuance to specific investors [1]

人民财讯11月25日电，北汽蓝谷(600733)11月25日公告，公司于11月24日收到中国证券监督管理委员会 出具的《关于同意北汽蓝谷新能源科技股份有限公司向特定对象发行股票注册的批复》。同意公司向特 定对象发行股票的注册申请。 转自：证券时报 ...